| P50 | author | Hugh Brady | Q58949320 |
| P2093 | author name string | M Coles | |
| | O Williams | |
| | S Taga | |
| | D Kioussis | |
| | G Gil-Gómez | |
| | M Tolaini | |
| | T Norton | |
| | C L Mok | |
| P2860 | cites work | Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins | Q24310631 |
| | Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death | Q24311298 |
| | Bcl-2 targets the protein kinase Raf-1 to mitochondria | Q24321753 |
| | The structure of the human CD2 gene and its expression in transgenic mice | Q24563712 |
| | Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery | Q27860586 |
| | BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity | Q28249553 |
| | Interference of BAD (Bcl-xL/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11 | Q28254663 |
| | Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt | Q28255373 |
| | Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells | Q28294137 |
| | Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L) | Q28297419 |
| | Apoptosis by death factor | Q28304002 |
| | Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis | Q28588677 |
| | A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry | Q29617253 |
| | The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase | Q29618387 |
| | Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells | Q30411850 |
| | CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. | Q34300766 |
| | Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. | Q34422208 |
| | Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene | Q35045775 |
| | T-cell receptor-specific monoclonal antibodies against a V beta 11-positive mouse T-cell clone | Q35113460 |
| | Expression and location of pro-apoptotic Bcl-2 family protein BAD in normal human tissues and tumor cell lines. | Q35764153 |
| | The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry | Q35917268 |
| | Bax alpha perturbs T cell development and affects cell cycle entry of T cells | Q35917304 |
| | Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase | Q36103541 |
| | Apoptosis and programmed cell death in immunity | Q36135180 |
| | The T cell receptor repertoire of CD4-8+ thymocytes is altered by overexpression of the BCL-2 protooncogene in the thymus | Q36362663 |
| | Positive selection is not required for thymic maturation of transgenic gamma delta T cells | Q36366715 |
| | The action of Bax and bcl-2 on T cell selection | Q36401807 |
| | Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice | Q37319686 |
| | Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. | Q37355656 |
| | Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL. | Q40024055 |
| | Regulation of lymphocyte survival by the bcl-2 gene family | Q40444925 |
| | Positive selection of lymphocytes | Q40807424 |
| | Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex. | Q41062034 |
| | T cells from baxalpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53. | Q41064142 |
| | Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin | Q41412030 |
| | The proto-oncogene Bcl-2 and its role in regulating apoptosis | Q41492030 |
| | The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy | Q41659044 |
| | Mechanism of activation and function of protein kinase B. | Q41732739 |
| | bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes | Q44192187 |
| | Bcl-2-family proteins: the role of the BH3 domain in apoptosis | Q47686942 |
| | The developmental fate of T cells is critically influenced by TCRgammadelta expression. | Q51097761 |
| | Interference of BAD (Bcl-xL/Bcl-2-Associated Death Promoter)-Induced Apoptosis in Mammalian Cells by 14-3-3 Isoforms and P11 | Q55868670 |
| | Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice | Q57222709 |
| | bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship | Q57338704 |
| | Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo | Q59082223 |
| | T-cell apoptosis detected in situ during positive and negative selection in the thymus | Q59087078 |
| | A Bad kinase makes good | Q59099312 |
| | Human CD2 3'-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice | Q69368112 |
| | Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis | Q71687705 |
| | Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice | Q72037334 |
| | Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor | Q72121269 |
| | Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F | Q73925270 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 575-586 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Bad can act as a key regulator of T cell apoptosis and T cell development | |
| P478 | volume | 189 | |